LifeStance announces secondary offering of 20M shares by selling stockholders; no proceeds to company

LifeStance Health Group, Inc.

Underwriting agreement signed May 21 for 20M shares (plus 3M option) sold by selling stockholders.
Company receives no proceeds; all shares offered by existing stockholders, including option shares.
Underwriters led by Morgan Stanley and Goldman Sachs; closing expected May 24, 2024.
Offering made under automatically effective Form S-3 registration statement filed same day.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.